Applied Genetic Technologies (AGTC) Misses Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Roth Capital Reiterates Buy For Applied Genetic Technologies (AGTC) Following Q3
May 12, 2015 7:24 AM EDTRoth Capital reiterates their Buy rating on Applied Genetic Technologies Corp. (NASDAQ: AGTC), and maintains a price target of $34.00, following F3Q15 results. AGTC reported EPS results of ($0.38), compared to estimates of ($0.30). Revenue was reported at $0.28M (vs. $0.6M estimate).
Roth Capital analyst, Joseph Pantginis, commented on the impact of the quarter, saying, "AGTC's fundamentals remain unchanged and we... More
Applied Genetic Technologies (AGTC) Files $125M Common Shelf
May 11, 2015 4:59 PM EDTApplied Genetic Technologies (NASDAQ: AGTC) filed a registration with the U.S. SEC to sell up to $125 million of its Common Stock.
... More